botwhe.blogg.se

Hypack syringe risperdal consta
Hypack syringe risperdal consta














Tardive Dyskinesia (TD): TD is a syndrome of potentially irreversible, involuntary, dyskinetic movements that may develop in patients treated with antipsychotic medications.Management should include immediate discontinuation of antipsychotic drugs and other drugs not essential to concurrent therapy, intensive symptomatic treatment and close medical monitoring, and treatment of any concomitant serious medical problems.

hypack syringe risperdal consta

#Hypack syringe risperdal consta full

Clinical manifestations include muscle rigidity, fever, altered mental status, and evidence of autonomic instability ( see full Prescribing Information). Neuroleptic Malignant Syndrome (NMS): NMS, a potentially fatal symptom complex, has been reported with the use of antipsychotic medications.RISPERDAL CONSTA ® is not approved for the treatment of patients with dementia-related psychosis. The incidence of CAEs was significantly higher than with placebo. Cerebrovascular Adverse Events (CAEs): CAEs (e.g., stroke, transient ischemia attacks), including fatalities, were reported in placebo-controlled trials in elderly patients with dementia-related psychosis taking oral risperidone.Contraindications: RISPERDAL CONSTA ® is contraindicated in patients with a known hypersensitivity to risperidone, paliperidone, or to any excipients in RISPERDAL CONSTA ®.RISPERDAL CONSTA ® is not approved for use in patients with dementia-related psychosis. See full prescribing information for complete Boxed Warning.Įlderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. WARNING: Increased Mortality in Elderly Patients with Dementia-Related Psychosis














Hypack syringe risperdal consta